Global Pharma-Biotech New-Build Report: 727 New Facilities Represent $52 Billion Potential

Global Pharma-Biotech New-Build Report: 727 New Facilities Represent $52 Billion Potential

Global Pharma-Biotech New-Build Report: 727 New Facilities Represent $52 Billion Potential


Attachment: pharmanewbuild

SUGAR LAND--February 28, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The Pharmaceutical-Biotech Industry has 727 reported facility new builds in the works throughout the globe. Collectively, the sites have generated 855 reported projects, representing a total reported capital investment of $52 billion, which translates to a per-site average of $71.5 million.

Within this article: $125 million medical devices plant in Bloomington, Indiana. Additional companies: General Motors Corporation (NYSE:GM)

Subscribe Now!(All Fields Required)

Standard Membership - Free